Keyphrases
Intensity-modulated Radiotherapy
100%
Tumor Volume
100%
Gross Tumor Volume
100%
Intensity-modulated Radiation Therapy
100%
Nasopharyngeal Carcinoma
100%
Disease-free Survival
33%
Therapeutic Outcome
33%
Locoregional Control
33%
Tumor
16%
Effective Treatment
16%
Multivariate Analysis
16%
Overall Survival
16%
Independent Risk Factors
16%
Cancer Patients
16%
Distant Metastasis
16%
University of Washington
16%
Prescription Drugs
16%
Radiotherapy
16%
Fractional Dose
16%
Treatment Modalities
16%
Platinum-based Chemotherapy
16%
Stage IV Disease
16%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
16%
Combined Surgery
16%
Regional Failure
16%
Radiotherapy Patients
16%
Oropharyngeal
16%
Locoregional Disease
16%
Computational Environment
16%
Late Toxicity
16%
Locally Advanced
16%
Mucositis
16%
Distant Metastasis-free Survival
16%
Oropharynx Squamous Cell Carcinoma
16%
Xerostomia
16%
Free Software
16%
Skin Toxicity
16%
Gastrostomy Tube Placement
16%
Concurrent Diseases
16%
Trismus
16%
Locoregional Control Rate
16%
Advanced Oropharyngeal Carcinoma
16%
Medicine and Dentistry
Neoplasm
100%
Intensity Modulated Radiation Therapy
100%
Oropharynx Carcinoma
100%
Diseases
37%
Disease Free Survival
25%
Overall Survival
12%
Squamous Cell Carcinoma
12%
Distant Metastasis
12%
Multivariate Analysis
12%
Gastrostomy
12%
Predictive Factor
12%
Oropharynx
12%
Mucositis
12%
Distant Metastasis Free Survival
12%
Xerostomia
12%
Skin Toxicity
12%
Trismus
12%
Radiation Therapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Oropharynx Carcinoma
100%
Diseases
37%
Disease Free Survival
25%
Overall Survival
12%
Chemotherapy
12%
Distant Metastasis
12%
Squamous Cell Carcinoma
12%
Mucosa Inflammation
12%
Oropharynx Cancer
12%
Xerostomia
12%
Skin Toxicity
12%
Distant Metastasis Free Survival
12%
Trismus
12%